The Effect of Surgical Incision Drep Use in Endotracheal Tube Fixation
Launched by HASAN KALYONCU UNIVERSITY · Feb 12, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to secure breathing tubes (endotracheal tubes) in premature infants to help prevent accidental removal (unplanned extubation) and to protect their delicate skin from damage. The researchers will use a special surgical tape and monitor how well it works by checking the babies' skin moisture, pH levels, and overall skin condition. The goal is to see if this new method can reduce complications for these vulnerable infants.
To participate in the trial, infants must be between 28-34 weeks of gestation and currently in the neonatal intensive care unit (NICU) on a mechanical ventilator. Babies who have skin conditions, circulation issues, or other significant health problems will not be included. Participants can expect close monitoring during the study, with assessments to ensure their skin remains healthy while using the new tape. This study is currently recruiting participants and aims to improve care for premature infants who need breathing support.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Preterm infants between 28-34 weeks of gestation hospitalized in neonatal intensive care unit,
- • Intubated infants on invasive mechanical ventilators,
- • Babies who were orally intubated were included in the study.
- Exclusion Criteria:
- • Congenital skin condition,
- • With circulatory problems,
- • Congenital anomalies and metabolic disorders,
- • Small for gestational age (SGA) and large for gestational age (LGA),
- • Unplanned extubation taking place,
- • Babies intubated for less than 24 hours will be excluded from the study.
About Hasan Kalyoncu University
Hasan Kalyoncu University is a distinguished academic institution dedicated to advancing research and education in the health sciences. With a commitment to innovation and excellence, the university actively sponsors clinical trials aimed at enhancing medical knowledge and improving patient outcomes. By fostering collaboration among researchers, healthcare professionals, and industry partners, Hasan Kalyoncu University strives to contribute to the development of effective therapies and interventions, ultimately aiming to address pressing health challenges and promote public well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Batman, , Turkey
Patients applied
Trial Officials
Barış Çelik
Principal Investigator
Hasan Kalyoncu University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported